Status:
UNKNOWN
Full Spectrum Hemp Observational Study
Lead Sponsor:
Charlotte's Web, Inc
Conditions:
Acne Vulgaris
Acne Vulgaris Superficial Mixed Comedonal and Inflammatory
Eligibility:
All Genders
13-70 years
Brief Summary
In westernized societies, acne vulgaris is nearly a universal skin disease afflicting 79% to 95% of the adolescent population; older than 25 years - 40% to 54% have facial blemishes and persists into ...
Detailed Description
Charlotte's Web Full spectrum hemp blemish product will contain a mere 0.018% THC and will therefor not impart a psychotic affect. Hemp has been shown to be well tolerated in humans and has a very acc...
Eligibility Criteria
Inclusion
- Male/female
- Diagnosed acne vulgaris
- Not on current acne treatment(s) or off current treatment for 2 weeks
- 13-70 yrs old
Exclusion
- Not willing to stop current acne treatment(s)
- males that present with facial hair
- active TB, HIV or hepatitis
- pregnant or lactating females
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04730414
Start Date
February 1 2021
End Date
December 1 2021
Last Update
February 1 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.